GlucoTrack, Inc. (GCTK)
0.4032
-0.20
(-32.67%)
USD |
NASDAQ |
Oct 23, 16:00
0.42
+0.02
(+4.17%)
After-Hours: 20:00
GlucoTrack Net Income (Quarterly) : -3.814M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.814M |
| March 31, 2026 | -4.334M |
| December 31, 2025 | -3.628M |
| September 30, 2025 | -4.171M |
| June 30, 2025 | -4.756M |
| March 31, 2025 | -6.833M |
| December 31, 2024 | -10.09M |
| September 30, 2024 | -5.087M |
| June 30, 2024 | -4.489M |
| March 31, 2024 | -2.927M |
| December 31, 2023 | -2.412M |
| September 30, 2023 | -2.223M |
| June 30, 2023 | -1.176M |
| March 31, 2023 | -1.286M |
| December 31, 2022 | -1.287M |
| September 30, 2022 | -0.928M |
| June 30, 2022 | -1.127M |
| March 31, 2022 | -1.093M |
| December 31, 2021 | -1.506M |
| September 30, 2021 | -0.804M |
| June 30, 2021 | -0.853M |
| March 31, 2021 | -0.904M |
| December 31, 2020 | -0.879M |
| September 30, 2020 | -0.509M |
| June 30, 2020 | -0.574M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.734M |
| December 31, 2019 | -0.5989M |
| September 30, 2019 | -0.9968M |
| June 30, 2019 | -0.8989M |
| March 31, 2019 | -1.022M |
| December 31, 2018 | -29.65M |
| September 30, 2018 | -1.573M |
| June 30, 2018 | -1.962M |
| March 31, 2018 | -1.848M |
| December 31, 2017 | -2.656M |
| September 30, 2017 | -2.585M |
| June 30, 2017 | -2.557M |
| March 31, 2017 | -2.530M |
| December 31, 2016 | -1.139M |
| September 30, 2016 | -1.455M |
| June 30, 2016 | -1.589M |
| March 31, 2016 | -1.227M |
| December 31, 2015 | -1.545M |
| September 30, 2015 | -1.096M |
| June 30, 2015 | -1.667M |
| March 31, 2015 | -1.534M |
| December 31, 2014 | -0.6703M |
| September 30, 2014 | -0.7696M |
| June 30, 2014 | 4.259M |
| March 31, 2014 | -0.7369M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Nuwellis, Inc. | -4.828M |
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.814M |
| EPS Diluted (Quarterly) | -11.42 |
| Enterprise Value | 1.003M |
| Earnings Yield | -44.75K% |
| Normalized Earnings Yield | -44755.83 |